Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series

Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series

ObjectivesThis study aimed to characterise the clinicopathological features and prognostic factors of a large cohort of Hungarian patients with adrenocortical cancer diagnosed between 2000-2021.Patients and methodsThis retrospective study included seventy-four patients (27 men and 47 women) with his...

Full description

Bibliographic Details
Main Authors: Judit Tőke, Andrea Uhlyarik, Júlia Lohinszky, Júlia Stark, Gergely Huszty, Tamás Micsik, Katalin Borka, Péter Reismann, János Horányi, Peter Igaz, Miklós Tóth
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Endocrinology
Subjects:
Adrenocortical cancer
prognostic markers
overall survival
mitotane
single centre experience
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.952418/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.952418/full

Similar Items